Home > Insider Trading > Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc. (ACRS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Hedge Funds Have Never Been This Bullish On Aclaris Therapeutics, Inc. (ACRS)

After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...

Keep Reading →

July 6th, 2021 - Hedge Funds News

Is ACRS Stock A Buy or Sell?

Is Aclaris Therapeutics, Inc.

Keep Reading →

April 26th, 2021 - Hedge Funds News

Is ACRS A Good Stock To Buy Now?

While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get cautious...

Keep Reading →

December 15th, 2020 - Hedge Funds News

Hedge Funds Are Buying Aclaris Therapeutics, Inc. (ACRS)

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.

Keep Reading →

October 14th, 2020 - Hedge Funds News

Is Aclaris Therapeutics, Inc. (ACRS) A Good Stock To Buy?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Keep Reading →

June 26th, 2020 - Hedge Funds News

Did Hedge Funds Drop The Ball On Aclaris Therapeutics, Inc. (ACRS) ?

Is Aclaris Therapeutics, Inc. (NASDAQ:ACRS) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.

Keep Reading →

December 12th, 2019 - Hedge Funds News

Here's What Hedge Funds Think About Aclaris Therapeutics, Inc. (ACRS)

"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.

Keep Reading →

July 5th, 2019 - Hedge Funds News

Do Hedge Funds Love Aclaris Therapeutics, Inc. (ACRS)?

Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge ...

Keep Reading →

December 23rd, 2018 - Hedge Funds News

Hedge Fund and Insider Trading News: Carl Icahn, Adage Capital Management, Pierre Andurand, Simpson Manufacturing Co, Inc. (SSD), Evans & Sutherland (ESCC), William Lyon Homes (WLH), and More

(Reuters) - SandRidge Energy Inc (SD.N) yielded to demands from top shareholder Carl Icahn on Monday and said it would evaluate any buyout offers, including one promised last week by the hedge fund manager...

Keep Reading →

April 9th, 2018 - Hedge Funds Insider Trading

13G Filing: James E. Flynn and Aclaris Therapeutics Inc (ACRS)

Aclaris Therapeutics Inc (NASDAQ:ACRS): James E. Flynn's Deerfield Management filed an amended 13D. You can check out Deerfield Management's latest holdings and filings here.

Keep Reading →

October 10th, 2017 - Hedge Funds